| Latest Sequenom News Headlines |
| Date | Time | Source | |
| 09/18/2008 | 9:00AM | PRNUS | Sequenom to Webcast Analyst and Investor Briefing Presentation on September 23
SAN DIEGO, Sept. 18 /PRNewswire-FirstCall/ -- Sequenom (NASDAQ:SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom Analyst and Investor Briefing." Details of the event are as follows:
What: SEQUENOM ANALYST... More...>> |
| 05/28/2008 | 4:05PM | PRNUS | Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:
What:... More...>> |
| 09/21/2007 | 4:05PM | PRNUS | Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
SAN DIEGO, Sept. 21 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom Today and Tomorrow." Details of the event are as follows:
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO... More...>> |
| 02/21/2007 | 4:00AM | PRNUS | Sequenom to Hold Fourth Quarter and Full-Year 2006 Financial Results Conference Call on March 7
SAN DIEGO, Feb. 21 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that it will release fourth quarter and full-year 2006 financial results before market open on Wednesday, March 7, 2007. Sequenom management will host an investment-community conference call at 1:00 p.m. Eastern Time (10:00 a.m... More...>> |
| 02/20/2007 | 4:00AM | PRNUS | Sequenom Names Financial Veteran Paul W. Hawran Chief Financial Officer
SAN DIEGO, Feb. 20 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that Paul W. Hawran, 54, has been appointed Chief Financial Officer effective April 1, 2007, and will report to Harry Stylli, Ph.D., President and Chief Executive Officer. Until April 1, Mr. Hawran will serve as a consultant to... More...>> |
| 02/13/2007 | 4:00AM | PRNUS | Sequenom Expands Non-Invasive Prenatal Diagnostic Intellectual Property Portfolio
SAN DIEGO, Feb. 13 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM), a leading provider of fine mapping genotyping, methylation and gene expression analysis solutions, today announced that it has acquired exclusive rights in territories including the United States, Europe, Australia, Canada and Japan as well as... More...>> |
| 02/09/2007 | 6:31PM | PRNUS | MultiVu Video Feed: New Data Supports a Non-Invasive Approach to Routine Prenatal Genetic Testing
Fetal Nucleic Acid Technology Offers Potential Alternative to Amniocentesis
SAN FRANCISCO, Feb. 9 /PRNewswire-FirstCall/ -- Research studies demonstrating the viability of an approach to routinely detect the presence of fetal DNA in a mother's blood to accurately diagnose or rule out genetic defects -- as early as the... More...>> |
| 02/09/2007 | 6:30PM | PRNUS | New Data Supports a Non-Invasive Approach to Routine Prenatal Genetic Testing
Fetal Nucleic Acid Technology Offers Potential Alternative to Amniocentesis
SAN FRANCISCO, Feb. 9 /PRNewswire-FirstCall/ -- Research studies demonstrating the viability of an approach to routinely detect the presence of fetal DNA in a mother's blood to accurately diagnose or rule out genetic defects -- as early as the... More...>> |
| 02/09/2007 | 4:00AM | PRNUS | Sequenom to Present at BIO CEO & Investor Conference 2007 on February 14
Webcast Scheduled February 14 at 3:00 P.M. Eastern Time
SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM), a leading provider of fine mapping genotyping, methylation and gene expression analysis solutions, today announced that Sequenom President and Chief Executive Officer Harry Stylli, Ph.D... More...>> |
| 02/05/2007 | 4:00AM | PRNUS | Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that it has named Steven Owings to the newly created position of Vice-President of Commercial Development, Prenatal Diagnostics. Mr. Owings will lead the Company's commercialization of its non-invasive prenatal diagnostic technology... More...>> |
| 01/29/2007 | 4:00AM | PRNUS | Sequenom and Lenetix Enter Agreement to Develop and Commercialize Rhesus D Prenatal Diagnostic
Sequenom's First Non-Invasive Prenatal Diagnostic Test On Track to Launch in First Half of 2007
SAN DIEGO and MINEOLA, N.Y., Jan. 29 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide... More...>> |
| 01/25/2007 | 4:00AM | PRNUS | Sequenom to Present Scientific Poster at the Society of Maternal-Fetal Medicine Annual Meeting
SAN DIEGO, Jan. 25 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that a Company-sponsored poster that confirms a key developmental milestone for future non-invasive prenatal diagnostic tests will be presented at the 27th Annual Meeting of the Society of Maternal-Fetal Medicine, to be held February... More...>> |
| 01/23/2007 | 4:00AM | PRNUS | Sequenom's iPLEX Gold Assay Receives Positive Feedback From Leading Genomic Research Institutions
SAN DIEGO, Jan. 23 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that its recently launched iPLEX(TM) Gold genotyping assay has been favorably received at The Broad Institute, a research collaboration of the Massachusetts Institute of Technology (MIT), Harvard and its affiliated hospitals, and... More...>> |
| 01/17/2007 | 4:00AM | PRNUS | Sequenom and Genus Enter Into Large Scale Livestock Genotyping Services Contract
SAN DIEGO, Jan. 17 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that it will provide contract genotyping services to Genus plc (LSE:GNS), a world leader in applying quantitative genetics and biotechnology to livestock breeding, for a number of large-scale, high-throughput genotyping projects... More...>> |
| 01/10/2007 | 4:00AM | PRNUS | Sequenom Reports Multiple MassARRAY System Sales in South Korea
SAN DIEGO, Jan. 10 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that through its exclusive South Korean distributor Bioneer Corporation (Kosdaq: 064550) the Company sold three MassARRAY(R) genetic analysis systems in the region during the fourth quarter of 2006 including a sale to the world-class... More...>> |
| 01/09/2007 | 6:00AM | PRNUS | Genome Institute of Singapore Upgrades Genetic Analysis Facility With Investment in Sequenom's MassARRAY Technology
SAN DIEGO, Jan. 9 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that the highly regarded, state-of-the-art Genome Institute of Singapore (GIS), a member of the Agency for Science, Technology and Research (A*STAR), has significantly expanded its nucleic acid analysis capabilities by upgrading... More...>> |
| 01/09/2007 | 4:00AM | PRNUS | Study Published in 'Nature Medicine' Shows Sequenom's MassARRAY Platform Enables Noninvasive Prenatal Detection of Down Syndrome
SAN DIEGO, Jan. 9 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that a research study published in the Nature Medicine advance online publication, January 7, 2007 (doi:10.1038/nm1530) shows the noninvasive prenatal determination of fetal trisomy 21 (Down syndrome) using Sequenom's MassARRAY(R... More...>> |
| 01/08/2007 | 2:00AM | PRNUS | Sequenom and QIAGEN Enter Into Collaboration Targeting Prenatal Diagnostics
SAN DIEGO and VENLO, Netherlands, Jan. 8 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) and QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), today announced that they have entered into a strategic collaboration to jointly develop a gold-standard preanalytical... More...>> |
| 12/11/2006 | 4:00AM | PRNUS | Bovigen Announces USDA Process Verification Program Approval
Bovigen, LLC Recognized as the First DNA Testing Provider to Have Been Successfully Audited and Approved by the United States Department of Agriculture Under Its Process Verified Program
HARAHAN, La. and SAN DIEGO, Dec. 11 /PRNewswire-FirstCall/ -- Bovigen, LLC today announced that the U.S. Department of Agriculture... More...>> |
| 11/06/2006 | 4:00AM | PRNUS | Study Published in 'Nature Genetics' by the University of California, San Diego Utilizes SEQUENOM's MassARRAY System in a Compre
SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (NASDAQ:SQNM) today announced that the Department of Bioengineering at the University of California, San Diego (UCSD) has implemented the MassARRAY(R) system using its comparative sequencing application and its quantitative genotyping application to conduct... More...>> |